Headache Research Advances Though Cures Are Elusivenews2021-07-23T09:00:14+00:00July 23rd, 2021|The New York Times|
How an Unproven Alzheimer’s Drug Got Approvednews2021-07-20T02:12:00+00:00July 20th, 2021|The New York Times|
Ohio Clinic Says It Won’t Administer Alzheimer’s Drug to Patientsnews2021-07-15T03:11:54+00:00July 15th, 2021|The New York Times|
BioBonds Use Wall Street Tools to Fund Medical Researchnews2021-07-12T10:47:53+00:00July 12th, 2021|The New York Times|
¿Te preocupa la variante Delta? Las investigaciones muestran que las vacunas son eficaces contra ellanews2021-07-09T19:31:41+00:00July 9th, 2021|The New York Times|
In Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s Drugnews2021-07-09T19:12:53+00:00July 9th, 2021|The New York Times|
Citing the Delta Variant, Pfizer Will Pursue Booster Shots and a New Vaccinenews2021-07-09T01:51:11+00:00July 9th, 2021|The New York Times|
Just released: PhRMA members’ new clinical trial diversity principlesnews2020-11-18T13:00:00+00:00November 18th, 2020|The Catalyst|
